Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a simple supplement revive sperm health and testosterone?

NCT ID NCT07740161

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This trial tests whether a daily supplement called WeNatal For Him can improve markers of male fertility, including sperm quality, testosterone levels, energy, and libido. Forty men aged 30 and older who report low energy and low libido will take three capsules each morning for three months. Researchers will measure changes in sperm parameters and hormone levels, and track participants' self-reported reproductive and sexual health.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
WeNatal For Him supplement (a dietary supplement taken as 3 capsules daily)
What this could lead to
If successful, this supplement could offer a simple daily option to support male fertility and vitality, potentially improving sperm quality and testosterone levels.
What could go wrong
This is a small, early-stage, single-arm trial with no placebo group, so results may not be conclusive or generalizable. The supplement's effects on fertility are not guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Apr 2025

Finished

Sep 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Be male * Be aged 30+ * Anyone currently experiencing issues regarding low energy and low libido * Anyone who is generally healthy - does not live with any uncontrolled chronic disease * Willing to stop taking any other products or prescription medication, herbal remedies, or supplements for the duration of the study that target fertility, reproductive health, and sexual health * Not planning on introducing any products or any new prescription medication, herbal remedies, or supplements that target male fertility, reproductive health, or sexual health for the study duration * Resides in the United States * Not currently partaking in another research study and will not be partaking in any other research study for the next 3 months and at any point during this study's duration * Willing to provide a semen sample via masturbation * Willing to abstain from ejaculation for a minimum of 48 hours and a maximum of 5 days before providing the semen sample * Willing to abstain from marijuana products during the entire study duration Exclusion Criteria: * Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders * Anyone who has ever taken supplemental testosterone * Anyone planning to undergo any surgeries or invasive treatments for the study duration * Anyone who has had a major illness in the last 3 months * Anyone currently undergoing any type of fertility treatment * Anyone with any allergies or sensitivities to any of the study product ingredients * Anyone unwilling to follow the study protocol * Anyone taking anticoagulant or 'blood thinner' medication * Anyone undergoing chemotherapy * Anyone taking insulin or diabetes medication * Anyone who drinks heavily (i.e. 8 or more alcoholic drinks per week for women or 15 or more alcoholic drinks per week for men) * Anyone with a history of substance abuse * Anyone who is currently a smoker or has been a smoker in the past 3 months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Low energy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Citruslabs

    Las Vegas, Nevada, 89118, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.